Ying Jiang, Ph.D.

ORS DTP
US Food and Drug Administration

Poster(s):

• (M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
  Monday, October 21, 2024

  9:30 AM – 10:30 AM MT

• (W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
  Wednesday, October 23, 2024

  11:30 AM – 12:30 PM MT

• (T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
  Tuesday, October 22, 2024

  11:30 AM – 12:30 PM MT

• (W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence
  Wednesday, October 23, 2024

  11:30 AM – 12:30 PM MT

• (M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
  Monday, October 21, 2024

  12:30 PM – 1:30 PM MT

• (T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
  Tuesday, October 22, 2024

  1:30 PM – 2:30 PM MT